Oncology

E.R. Fearon, K.R. Cho, J.M. Nigro, S.E. Kern, et al., "Identification of a chromosome 18q gene that is altered in colorectal cancers," Science, 247, 49-56, 5 January 1990. Eric R. Fearon (Johns Hopkins University School of Medicine, Baltimore): "Tumor suppressor genes appear crucial for the development of many forms of human cancer. In the cited study, we attempted to identify a tumor suppressor gene on chromosome 18q. Starting from a region of chromosome 18 that we suspected to contain this

| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

E.R. Fearon, K.R. Cho, J.M. Nigro, S.E. Kern, et al., "Identification of a chromosome 18q gene that is altered in colorectal cancers," Science, 247, 49-56, 5 January 1990.

Eric R. Fearon (Johns Hopkins University School of Medicine, Baltimore): "Tumor suppressor genes appear crucial for the development of many forms of human cancer. In the cited study, we attempted to identify a tumor suppressor gene on chromosome 18q. Starting from a region of chromosome 18 that we suspected to contain this gene, we cloned a large stretch of DNA (370 kilobases) by chromosome walking techniques. Taking advantage of homologous sequences in the rat, and a sensitive assay for RNA expression, we were eventually able to identify a gene, called DCC (for deleted in colorectal cancer), that was somatically mutated in some colorectal cancers and expressed at reduced levels in most colorectal tumors. The predicted amino acid sequence of this gene specified ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies